Walk Test With Smartphone Sensor Can Classify Fall Risk in Amputees
FRIDAY, Aug. 19, 2022 (HealthDay News) — In lower-limb amputees, automated foot strikes from a six-minute walk test (6MWT) can be used to calculate step-based features for fall risk classification, according to a study published online Aug. 18 in PLO…
Learn MoreSMART Work and Life Intervention Reduces Sitting Time for Office Workers
FRIDAY, Aug. 19, 2022 (HealthDay News) — An intervention can reduce sitting time at work, with greater improvement with the use of a height-adjustable desk, according to a study published online Aug. 17 in The BMJ.
Charlotte L. Edwardson, Ph.D., …
Learn MoreClinical Management Guidelines Lacking for Monkeypox
FRIDAY, Aug. 19, 2022 (HealthDay News) — There is a lack of evidence-based clinical management guidelines for monkeypox (MPX), according to a review published online Aug. 16 in BMJ Global Health.
Eika Webb, M.B.B.S., from Liverpool School of Tropic…
Learn MoreMetformin, Ivermectin, Fluvoxamine Do Not Prevent Severe COVID-19
FRIDAY, Aug. 19, 2022 (HealthDay News) — For patients with COVID-19 infection, metformin, ivermectin, and fluvoxamine do not prevent the occurrence of hypoxemia, an emergency department visit, hospitalization, or death, according to a study publish…
Learn MoreLower Glycemic Criteria for GDM Does Not Cut Risk for LGA Infants
FRIDAY, Aug. 19, 2022 (HealthDay News) — Use of lower glycemic criteria for the diagnosis of gestational diabetes does not alter the risk for large-for-gestational-age infants, according to a study published in the Aug. 18 issue of the New England Jo…
Learn MoreDay Care Tied to Morbidity in Children Born Preterm With BPD
FRIDAY, Aug. 19, 2022 (HealthDay News) — For children born preterm with bronchopulmonary dysplasia (BPD), those attending day care have increased likelihood of emergency department visits and systemic steroid usage, according to a study published …
Learn MoreGemcitabine/Docetaxel Treats Nonmuscle-Invasive Bladder Cancer
FRIDAY, Aug. 19, 2022 (HealthDay News) — Gemcitabine plus docetaxel (Gem/Doce) may be an alternative for the treatment of high-risk non-muscle-invasive bladder cancer (NMIBC), according to a study published in the September issue of The Journal of Ur…
Learn MoreEfficacy of Durvalumab for Early-Stage TNBC Examined by Race
FRIDAY, Aug. 19, 2022 (HealthDay News) — Among patients with early-stage triple-negative breast cancer (TNBC), the pathologic complete response (pCR) rate for durvalumab added to neoadjuvant chemotherapy is 46 percent, with similar rates for African …
Learn MoreCases of Advanced Cervical Cancer Keep Rising Among U.S. Women
FRIDAY, Aug. 19, 2022 (HealthDay News) — New research points to a conundrum with cervical cancer: While rates of early-stage disease have been dropping in the United States ever since the human papillomavirus (HPV) vaccine was introduced, advanced ca…
Learn MoreMajor Gene Study Spots DNA Tied to Autism, Other Disorders
FRIDAY, Aug. 19, 2022 (HealthDay News) — More than 70 genes are very strongly associated with autism and more than 250 are linked to the condition, a major new genetic analysis has revealed.The analysis is the largest of its kind to date, involving m…
Learn More